Tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15858517.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Xanthomas most often occur in conjunction with a primary or secondary disorder of lipid metabolism. A range of metabolic disturbances has been described in association with protease inhibitors, including lipodystrophy, hyperglycemia, and hyperlipidemia. Ritonavir has been repeatedly shown to be the most common protease inhibitor to induce these metabolic abnormalities. This report highlights a case of both tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.
Medical subject headings
- HIV Infections
- HIV Protease Inhibitors
- Hyperlipidemias
- Ritonavir
- Xanthomatosis